Dr. Narimatsu is an Associate Professor at Copenhagen Center for Glycomics, Ph.D. (2008, Tsukuba University, Japan). His study focuses on the structure, biosynthesis, and genetic regulation of complex carbohydrates. He received training for eight years at the glycobiology lab, Research Center for Medical Glycoscience (RCMG) in Japan. Joined a Center of Excellence in Glycomics funded by the Danish National Research Foundation at the University of Copenhagen in 2012 and contributed to developing a comprehensive and high-throughput platform for CRISPR/Cas9 gene targeting of the human glycome (GlycoCRISPR), a large library of glycoengineered cells (GlycoDisplay), a cell-based platform for the display and production of human Mucin tandem repeat (MucinDisplay). His research interests include a basic understanding of genetic regulation and biosynthesis of protein glycosylation, consequences of deficiencies in glycosylation in diseases, and biomedical applications.
His group has taken a global "glycogenome" engineering approach to protein glycosylation and proposed a Cell-Based glycan array platform to display the human glycome–i.e., display of all human glycans on proteins, proteoglycans, and lipids. This self-renewable array is useful for discovering biological interactions involving glycans, and screening of true high-affinity interactions with glycans requires the natural biological context of specific proteins and cell surfaces.